Experimental cancer drug trial halted early
NCT ID NCT05607199
First seen May 14, 2026 · Last updated May 14, 2026
Summary
This early-stage study tested a new drug called AUR103 Calcium in 27 adults with advanced cancers that had stopped responding to standard treatments. The goal was to find a safe dose and see how the drug worked in the body. The trial was terminated early, so no final results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-HODGKIN LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
All India Institute of Medical Sciences
Delhi, National Capital Territory of Delhi, 10029, India
-
Grant Medical Foundation Ruby Hall Clinic
Pune, Maharashtra, 411001, India
-
K R Hospital
Mysore, Karnataka, 570001, India
-
Kiran Multi Super Specialty Hospital
Surat, Gujarat, 395004, India
-
Unique Hospital
Surat, Gujarat, 395002, India
Conditions
Explore the condition pages connected to this study.